Cargando…
Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19
Autor principal: | Shah, Adnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248552/ https://www.ncbi.nlm.nih.gov/pubmed/32574259 http://dx.doi.org/10.3389/fimmu.2020.01021 |
Ejemplares similares
-
Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023) -
Targeting the NLRP3 Inflammasome in Severe COVID-19
por: Freeman, Tracey L., et al.
Publicado: (2020) -
Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer
por: Tezcan, Gulcin, et al.
Publicado: (2021) -
Editorial: Novel perspectives on the NLRP3 inflammasome
por: Liang, Ying, et al.
Publicado: (2023) -
The NLRP3 inflammasome as a new target in respiratory disorders treatment
por: Leszczyńska, Katarzyna, et al.
Publicado: (2022)